Customers who received an affected sample through the physician's office should have received a letter from their physician. Adverse events can be reported to Novo Nordisk's customer care center ...

(RTTNews) - Novo Nordisk said that the US Food and Drug Administration has issued a Complete Response Letter or CRL covering the Biologics License Application for once-weekly basal insulin icodec ...

Bagsværd, Denmark 7 October 2016 - Novo Nordisk today announced that it has received a Complete Response Letter from the US Food and Drug Administration (FDA) regarding the New Drug Application ...

Bagsværd, Denmark, 10 February 2013 - Novo Nordisk today announced that on 8 February 2013 it received a Complete Response Letter from the US Food and Drug Administration (FDA) regarding the New ...